NEW YORK (GenomeWeb News) — Decode Genetics has netted $18.4 million after selling and leasing back its Chicago-area medicinal chemistry facility, the company said today.
 
The company sold the Woodridge, Ill., facility for $25 million and leased the space back for a 17-year term, Decode said.
 
Decode said it plans to use the cash it made on the deal to fund its drug- and diagnostic-development programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.